HORIZONFP7H2020
Fakultni Nemocnice v Motole
- Country
- CZCzechia
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 2,453,262
- Active
- 2011 to 2025
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CHARLESTONCHARLES University Programme for Sustainable Goals, Training, Openness and Novelty in Research | HORIZON | 2025 | Associated partner | EUR 0 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 156,800 |
| MONALISAA SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis | HORIZON | 2024 | Participant | EUR 417,976 |
| IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020 | HORIZON | 2023 | Participant | EUR 107,500 |
| EDENT1FIEuropean action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception | HORIZON | 2023 | Participant | EUR 413,125 |
| IDEA4RCIntelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers | HORIZON | 2022 | Participant | EUR 227,996 |
| ChiLTERNChildren’s Liver Tumour European Research Network | H2020 | 2016 | Participant | EUR 36,725 |
| NISCIAntibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial | H2020 | 2016 | Participant | EUR 158,718 |
| VISION DMDVISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy | H2020 | 2016 | Participant | EUR 168,625 |
| DISCHARGEDiagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies | FP7 | 2014 | Participant | EUR 113,220 |
| PANCARELIFEPanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood | FP7 | 2013 | Participant | EUR 194,644 |
| EPISTOPLong-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex | FP7 | 2013 | Participant | EUR 290,512 |
| INTREALLInternational study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research | FP7 | 2011 | Participant | EUR 167,420 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.